GENELUX Corp

GNLX

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001231457

SEC filings (opens in a new tab)

In the last 90 days, GENELUX Corp insiders filed 0 open-market purchases and 6 sales; 72 institutions reported holding it in 13F filings for Q2 2026, worth $29.5M in total; no superinvestor holds it.

Q2 2023 vs. Q1 2023

How the institutions holding GENELUX Corp changed between Q1 2023 and Q2 2023.

All holders in Q2 2023 All holders in Q1 2023

13F holders of GNLX: Q1 2023 compared with Q2 2023
Measure	Q1 2023	Q2 2023	Change
Holders	21	35	+14
Shares	287.4K	497.5K	+210.1K (+73.1%)
Value	$7.97M	$16.3M	+$8.30M (+104.2%)

New holders (17)

Institutions that held GENELUX Corp at the end of Q2 2023 but not at the end of Q1 2023.

Institutions new to GNLX in Q2 2023
Institution	Shares	Value	% of portfolio
LifeSteps Financial, Inc.	13,379	$437.8K	0.43%
AE Wealth Management LLC	13,257	$433.8K	0.00%
Bank of New York Mellon Corp	9,354	$306.1K	0.00%
Mark Stevens	9,328	$305.2K	0.04%
Jane Street Group, LLC	7,226	$236.4K	0.00%
Atlas Private Wealth Advisors	6,120	$200.2K	0.04%
Exchange Traded Concepts, LLC	4,442	$145.3K	0.00%
Bank of America Corp	3,200	$104.7K	0.00%
New York State Common Retirement Fund	2,900	$94.9K	0.00%
Rhumbline Advisers	2,789	$91.3K	0.00%
Global Retirement Partners, LLC	2,500	$81.8K	0.00%
American International Group, Inc.	1,332	$43.6K	0.00%
California State Teachers Retirement System	920	$30.1K	0.00%
STRS Ohio	600	$19.0K	0.00%
Amalgamated Bank	307	$10.0K	0.00%
Legal & General Group Plc	267	$8.58K	0.00%
Ameritas Investment Partners, Inc.	228	$7.46K	0.00%

Sold out (3)

Institutions that held GENELUX Corp at the end of Q1 2023 and filed for Q2 2023 without it.

Institutions that sold out of GNLX in Q2 2023
Institution	Shares, Q1 2023	Value, Q1 2023
Citadel Advisors LLC	10,615	$294.5K
Millennium Management LLC	8,763	$243.0K
Goldman Sachs Group Inc	8,647	$239.9K